Dr. Guthrie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
425 N Lee St
Ste 204
Jacksonville, FL 32204Phone+1 904-427-1200Fax+1 239-931-7385
Education & Training
- Medical College of GeorgiaFellowship, Hematology and Medical Oncology, 1977 - 1979
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1971 - 1974
- Medical College of Georgia at Augusta UniversityClass of 1971
Certifications & Licensure
- FL State Medical License 1994 - 2025
- GA State Medical License 1972 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
- Join now to see all
Publications & Presentations
PubMed
- 476 citationsRandomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung CancerNasser H. Hanna, Paul A. Bunn, Corey Langer, Lawrence H. Einhorn, Troy H. Guthrie
Journal of Clinical Oncology. 2006-05-01 - 1662 citationsTalimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced MelanomaRobert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio, Thomas Amatruda, Neil Senzer
Journal of Clinical Oncology. 2015-05-26 - 906 citationsIpilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging studyJedd D. Wolchok, Bart Neyns, Gerald P. Linette, Sylvie Negrier, Jose Lutzky
The Lancet. Oncology. 2010-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: